Geneva, April 20 -- International Clinical Trials Registry received information related to the study (ChiCTR2600121991) titled 'Application value of cognitive fusion six-point localization for lead placement in stage I sacral neuromodulation' on April 8.
Study Type: Observational study
Study Design:
Sequential
Primary Sponsor: Sun-yat-sen memorial hospital
Condition:
Refractory lower urinary tract dysfunction and pelvic floor dysfunction disorders
Intervention:
cognitive fusion six-point localization for lead placement in stage I sacral neuromodulation:None
Recruitment Status: Not Recruiting
Phase: Retrospective study
Date of First Enrollment: 2026-04-15
Target Sample Size: cognitive fusion six-point localization for lead p...